Danaher Co. (NYSE:DHR) Shares Bought by Everence Capital Management Inc.

by · The Cerbat Gem

Everence Capital Management Inc. raised its stake in Danaher Co. (NYSE:DHR – Free Report) by 6.4% in the third quarter, HoldingsChannel.com reports. The fund owned 23,794 shares of the conglomerate’s stock after purchasing an additional 1,440 shares during the quarter. Everence Capital Management Inc.’s holdings in Danaher were worth $5,903,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. DHJJ Financial Advisors Ltd. purchased a new stake in shares of Danaher in the third quarter valued at $25,000. IAG Wealth Partners LLC grew its position in shares of Danaher by 344.8% in the second quarter. IAG Wealth Partners LLC now owns 129 shares of the conglomerate’s stock valued at $31,000 after purchasing an additional 100 shares during the period. Raleigh Capital Management Inc. grew its position in shares of Danaher by 68.9% in the first quarter. Raleigh Capital Management Inc. now owns 125 shares of the conglomerate’s stock valued at $32,000 after purchasing an additional 51 shares during the period. WFA of San Diego LLC purchased a new stake in shares of Danaher in the second quarter valued at $32,000. Finally, First Capital Advisors Group LLC. purchased a new stake in shares of Danaher in the second quarter valued at $32,000. 76.71% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.0 %

Shares of DHR traded up $0.01 during midday trading on Friday, reaching $230.36. 1,577,024 shares of the company were exchanged, compared to its average volume of 3,221,786. The stock has a 50-day moving average price of $210.96 and a 200-day moving average price of $233.15. The company has a market cap of $170.22 billion, a price-to-earnings ratio of 29.05, a P/E/G ratio of 2.30 and a beta of 0.84. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $247.62. The company has a current ratio of 2.26, a quick ratio of 1.94 and a debt-to-equity ratio of 0.37.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Tuesday, October 24th. The conglomerate reported $2.02 EPS for the quarter, topping the consensus estimate of $1.83 by $0.19. Danaher had a return on equity of 13.71% and a net margin of 20.01%. The business had revenue of $6.87 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the previous year, the firm posted $2.56 earnings per share. The company’s revenue was down 10.3% compared to the same quarter last year. Research analysts expect that Danaher Co. will post 8.3 earnings per share for the current year.

Danaher Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is 12.11%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on DHR shares. Barclays lowered their price objective on Danaher from $290.00 to $215.00 and set an “overweight” rating for the company in a research report on Thursday, October 26th. TheStreet raised Danaher from a “c+” rating to a “b-” rating in a research report on Friday, December 8th. KeyCorp lowered their price target on Danaher from $300.00 to $260.00 and set an “overweight” rating for the company in a research report on Wednesday, October 25th. Raymond James lowered their price target on Danaher from $250.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, October 25th. Finally, StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a research report on Wednesday. Six analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $259.40.

Get Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).